癌症
Study links uneven PARP inhibitor exposure in ovarian tumors to lysosomal drug “reservoirs”
由 AI 报道 AI 生成的图像 事实核查
Researchers say they have identified a cellular mechanism that may help explain why PARP inhibitors can affect tumor cells unevenly: in lab-grown slices of human ovarian tumors, some of these drugs accumulated inside lysosomes, forming slow-release stores that created patchy drug distribution across tissue and even between neighboring cells. The findings were reported in a 2026 paper in Nature Communications.
最高法院大法官玛丽亚·菲洛梅娜·辛格（Maria Filomena Singh）在接受Rappler采访时，谈到了她的抗癌经历以及对司法领域性别平等的倡导。该节目作为“Rappler Talk”系列的一部分于3月27日播出。作为性别响应委员会的联合主席，她正积极推动各项改革，以更好地为法律体系中的女性提供服务。
由 AI 报道
A new poll reveals that nearly half of U.S. adults do not know processed meat is linked to higher colorectal cancer risk. Conducted by the Physicians Committee for Responsible Medicine and Morning Consult, the survey of 2,202 adults from February 9 to 11, 2026, found strong support for warning labels after respondents learned of the connection. Experts highlight the need for better education amid rising cases in younger adults.
The Kenyan government has raised the Social Health Authority's oncology treatment package from Ksh550,000 to Ksh800,000 per patient. Interior Principal Secretary Raymond Omollo announced the increase on March 16, 2026, amid public outcry over treatment costs. The package covers diagnosis, chemotherapy, radiotherapy, brachytherapy, surgical interventions, palliative care, consumables, and specialised imaging like PET/CT scans and MRIs at contracted facilities.
由 AI 报道
Researchers tested a redesigned CD40 agonist antibody, 2141-V11, by injecting it directly into tumors of 12 patients with metastatic cancers. Six patients saw tumor shrinkage, with two achieving complete remission, including effects on untreated tumors elsewhere in the body. The trial reported only mild side effects, unlike prior CD40 therapies.
Researchers at Uppsala University are launching a new treatment study to help young adults who have had cancer address issues related to sexuality and fertility. Around 40 participants aged 18-39 are involved in a 12-week internet-based program. The study is expected to include a total of about 250 people.
由 AI 报道
Researchers at Oregon Health & Science University have created a molecule called SU212 that blocks a key enzyme in triple-negative breast cancer cells. In mouse models, the compound reduced tumor growth and metastasis. The findings offer potential new treatment options for this hard-to-treat form of the disease.
Michigan mother sentenced to life for denying son cancer care
March 24, 2026 00:42President declares health alert over oncology waiting lists
March 23, 2026 14:54Study links Caspase-2 deficiency to higher liver cancer risk in mice
March 23, 2026 11:01New blood test improves early detection of pancreatic cancer
March 21, 2026 16:37UNIGE researchers unveil AI tool predicting cancer metastasis
March 16, 2026 15:21Cells can sense 10 times farther than expected, a finding that may shed light on cancer spread
March 15, 2026 19:16University of Missouri team tests anti-EphA2 antibody fragment to light up tumors on PET scans
March 13, 2026 23:47Severe COVID or flu may raise lung cancer risk years later
March 13, 2026 04:30Study links dual colon polyps to higher risk of advanced precancerous changes
March 12, 2026 22:32Mirror-image cysteine slows cancer growth without harming healthy cells